Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2012-12-10 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RUEIL-MALMAISON (92500), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DU CENTRE COLMAR : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU CENTRE COLMAR is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RUEIL-MALMAISON (92500),
this company of category PME
shows in 2022 a revenue of 3.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU CENTRE COLMAR (SIREN 789487212)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
3 089 139 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
102 813 €
84 046 €
164 634 €
253 528 €
197 348 €
83 447 €
160 508 €
145 048 €
152 642 €
EBITDA
N/C
N/C
238 466 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
5.3%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE DU CENTRE COLMAR generates positive net income of 103 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 153 k€ -> 103 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
102 813 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 160%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
160.207%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
32.429%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU CENTRE COLMAR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
359.126
253.478
182.162
1622.288
697.855
369.885
266.951
209.083
160.207
Financial autonomy
18.893
24.246
31.116
5.176
11.029
18.943
24.485
27.777
32.429
Repayment capacity
None
None
None
None
None
None
11.17
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
5.757%
None%
None%
Sector positioning
Debt ratio
160.212024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of SELARL PHARMACIE DU CENTR... (160.21) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
32.43%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of SELARL PHARMACIE DU CENTR... (32.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
11.17 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL PHARMACIE DU CENTR... (11.17) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 122.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
122.358
Liquidity indicators evolution SELARL PHARMACIE DU CENTRE COLMAR
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
114.033
105.753
102.646
180.922
221.528
244.769
236.263
159.716
122.358
Interest coverage
None
None
None
None
None
None
6.333
None
None
Sector positioning
Liquidity ratio
122.362024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch-38 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DU CENTR... (122.36) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
6.33x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of SELARL PHARMACIE DU CENTR... (6.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DU CENTRE COLMAR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
269 836 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
30
0
0
Customer payment term (days)
0
0
0
0
0
0
2
0
0
Supplier payment term (days)
0
0
0
0
0
0
40
0
0
Positioning of SELARL PHARMACIE DU CENTRE COLMAR in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DU CENTRE COLMAR is estimated at
1 435 345 €
(range 999 551€ - 2 147 358€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
999k€1435k€2147k€
1 435 345 €Range: 999 551€ - 2 147 358€
NAF 5 année 2024
Valuation method used
Net Income Multiple
102 813 €
×
14.0x
=1 435 345 €
Range: 999 552€ - 2 147 359€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU CENTRE COLMAR with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU CENTRE COLMAR
What is the revenue of SELARL PHARMACIE DU CENTRE COLMAR ?
The revenue of SELARL PHARMACIE DU CENTRE COLMAR in 2022 is 3.1 M€.
Is SELARL PHARMACIE DU CENTRE COLMAR profitable?
Yes, SELARL PHARMACIE DU CENTRE COLMAR generated a net profit of 103 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DU CENTRE COLMAR ?
The headquarters of SELARL PHARMACIE DU CENTRE COLMAR is located in RUEIL-MALMAISON (92500), in the department Hauts-de-Seine.
Where to find the tax return of SELARL PHARMACIE DU CENTRE COLMAR ?
The tax return of SELARL PHARMACIE DU CENTRE COLMAR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU CENTRE COLMAR operate?
SELARL PHARMACIE DU CENTRE COLMAR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart